Beverage giant Coca-Cola Co. (KO) reported a 26% jump in earnings for the third quarter helped by a decline in costs and expenses. The top and bottom line came in above analysts’ expectations. Following this, the stock inched up over 1% in the premarket session.
Net income climbed 26% to $1.81 billion and earnings jumped 31% to $0.44 per share. Comparable EPS from continuing operations grew 14% to $0.58.
Net operating revenues fell 9% to $8.25 billion. The top line was hurt by a 13 points headwind from the refranchising of company-owned bottling operations. Organic revenue increased 6% on concentrate sales growth of 4% that benefited from the timing of shipments and price/mix growth of 2%.
Unit case volume grew 2%, led by Trademark Coca-Cola. The company continued to gain value share in total nonalcoholic ready-to-drink (NARTD) beverages. Price/mix rose 2% for the quarter led by solid performance in the core business. Concentrate sales increased 2 points ahead of unit case volume largely due to the timing of shipments within Latin America.
Sparkling soft drinks rose 2% on Trademark Coca-Cola along with strong growth in the low- and no-calorie offerings of Sprite and Fanta. Water, enhanced water and sports drinks increased 5% on strong growth of water in single-serve packaging in China and Mexico along with the premium offerings in North America.
Juice, dairy, and plant-based beverages fell 3% as challenging macroeconomic environment hurt the Middle East and North Africa as well as package downsizing in North America impacted the results. Tea and coffee declined 2% due to a decline in its local tea brand in Turkey and the impact of Nestea resulting from the dissolution of Beverage Partners Worldwide.
Coca-Cola also announced several strategic actions, including a number of acquisitions and investments, and continued to lift, shift and scale brands around the world. The company’s disciplined growth strategies and an ongoing focus on productivity led to double-digit profit growth for the quarter.
Looking ahead into the full year 2018, the company still expects organic revenues to increase at least 4% and comparable currency neutral operating income growth of at least 9%. Capital expenditures are still anticipated to be about $1.7 billion and cash from operations are predicted to be about $8 billion. Comparable EPS from continuing operations are projected to increase in the range of 8% to 10% from $1.91 in 2017.
Shares of Coca-Cola ended Monday’s regular session up 1.18% at $46.46 on the NYSE. The stock has risen over 1% in the year so far and 0.85% in the past year.
Listen to publicly listed companies’ earnings conference calls along with the edited closed caption text.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on